Derivados de Quinazolina e Quinolina
As quinazolinas e quinolinas são compostos heterocíclicos contendo nitrogénio, com estruturas aromáticas que desempenham um papel fundamental na síntese de fármacos com atividade anticancerígena, antimicrobiana e anti-inflamatória. Os seus derivados apresentam modificações estruturais que otimizam a biodisponibilidade e a seletividade, permitindo o desenvolvimento de novos princípios ativos para diversas aplicações terapêuticas. Estes compostos são utilizados na fabricação de APIs para o tratamento do câncer, infeções, doenças neurodegenerativas e cardiovasculares. Além disso, os derivados de quinazolina e quinolina são essenciais na investigação de inibidores enzimáticos e no desenvolvimento de moléculas bioativas inovadoras.
Na CymitQuimica, oferecemos derivados de quinazolina e quinolina de alta pureza para aplicações em síntese química, desenvolvimento farmacêutico e biotecnologia.
Foram encontrados 65630 produtos de "Derivados de Quinazolina e Quinolina"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
2-Amino-5,6-dichloro-3(4H)-quinazoline acetic acid benzyl ester hydrobromide
CAS:<p>2-Amino-5,6-dichloro-3-(4H)-quinazoline acetic acid benzyl ester hydrobromide is a drug product that is used as an analytical reference standard for the identification of impurities in aminoglycosides. 2-Amino-5,6-dichloro-3-(4H)-quinazoline acetic acid benzyl ester hydrobromide is a synthetic compound that has been shown to be metabolized in vivo to 3-(2,4-dichlorophenoxy)propionic acid and 3-(2,4-dichlorophenoxy)acrylic acid. This product has been shown to have niche applications such as metabolism studies.</p>Fórmula:C17H15Cl2N3O2Pureza:Min. 95%Peso molecular:364.23 g/mol(Z)-Fluvoxamine - EP
CAS:Produto Controlado<p>(Z)-Fluvoxamine-EP is a drug product that is used as an analytical standard. It is a synthetic metabolite of fluvoxamine, which is a drug used for the treatment of depression. The synthesis of (Z)-fluvoxamine-EP is based on the asymmetric synthesis of fluvoxamine and the use of chiral chromatography to purify the product. This synthetic process allows for the production of high-purity (Z)-fluvoxamine-EP with a purity greater than 99%.</p>Fórmula:C15H21F3N2O2Pureza:Min. 95%Peso molecular:318.33 g/mol(1-Ethyl-1-methylpropyl)benzene
CAS:<p>(1-Ethyl-1-methylpropyl)benzene is an impurity of some drugs. It is a metabolite of the drug, and can be found in urine or blood samples as a result of its excretion from the body. (1-Ethyl-1-methylpropyl)benzene is used as an analytical standard for HPLC analysis. This chemical is not on the USP list of impurities, but it is listed on the pharmacopoeia. The CAS number for (1-Ethyl-1-methylpropyl)benzene is 1985-97-3.</p>Fórmula:C12H18Pureza:Min. 95%Peso molecular:162.27 g/mol3-(Methylamino)-5,6-dihydro-2H-1,4-thiazin-2-one oxime hydrochloride
CAS:<p>3-(Methylamino)-5,6-dihydro-2H-1,4-thiazin-2-one oxime hydrochloride is an analytical reagent used for HPLC analysis of the impurities in pharmaceutical products. It is a white crystalline solid with a melting point of 235°C. 3-(Methylamino)-5,6-dihydro-2H-1,4-thiazin-2-one oxime hydrochloride is used as a reference standard and has been assigned CAS No. 112233-23-5 by the Chemical Abstracts Service (CAS). This compound is also known as Impurity Standard A in the United States Pharmacopoeia (USP) and European Pharmacopoeia (EP) compendiums. 3-(Methylamino)-5,6-dihydro-2H-1,4-thiazin-2-one oxime</p>Fórmula:C5H9N3OS•HClPureza:Min. 95%Cor e Forma:PowderPeso molecular:195.67 g/mol2-Butyl-3-(3,5-diiodo-4-hydroxybenzoyl)benzofuran
CAS:<p>2-Butyl-3-(3,5-diiodo-4-hydroxybenzoyl)benzofuran is a benzofuran. It is a yellow solid that can be dissolved in water and alcohol.</p>Fórmula:C19H16I2O3Pureza:Min. 95%Peso molecular:546.14 g/mol3-O-Desethyl-5-O-desmethyl amlodipine
CAS:<p>3-O-Desethyl-5-O-desmethyl amlodipine is a drug product that can be used as an analytical reference standard. It is metabolized in vivo to form 5-O-desmethyl amlodipine, which is the active form of this drug. 3-O-Desethyl-5-O-desmethyl amlodipine is also an impurity in the drug product Amlodipine besylate and its CAS number is 1821498-25-2. The synthetic route for this compound starts with the reaction of 2,3,4,6 trichlorobenzeneethanol with sodium hydroxide followed by hydrogenation of the intermediate to yield 3-(2,6 dichlorophenyl) propanoic acid. This acid was then reacted with methylamine to yield 3-(2,6 dichlorophenyl)-N-[(methylamino) methyl]propionamide.</p>Fórmula:C17H19ClN2O5Pureza:Min. 95%Peso molecular:366.8 g/molBalsalazide Isopropyl ester
CAS:<p>Balsalazide Isopropyl ester is a synthetic compound that is used as an active pharmaceutical ingredient in the treatment of irritable bowel syndrome. Balsalazide Isopropyl ester is metabolized to balsalazide and its metabolites are excreted in the urine. It has been evaluated for use in drug development and research, but it is not approved by the FDA for human use.</p>Fórmula:C20H21N3O6Pureza:Min. 95%Peso molecular:399.4 g/molLabetalol EP Impurity C
CAS:<p>Labetalol EP Impurity C is a synthetic impurity standard that is used to calibrate HPLC columns and for the quantification of labetalol in drug products. Labetalol EP Impurity C is a metabolite of labetalol and has been shown to have similar pharmacological properties. Labetalol EP Impurity C is synthesized by ester hydrolysis. The purity of this compound exceeds 99%.</p>Fórmula:C16H18N2O3Pureza:Min. 95%Peso molecular:286.33 g/molPantoprazole impurity
CAS:<p>Pantoprazole is a proton pump inhibitor. It is used in the treatment of gastroesophageal reflux disease and other conditions involving excessive stomach acid production. The chemical name for Pantoprazole impurity is (E)-1-(4-chlorophenyl)ethyl-3-[(pyrrolidin-2-yl)oxy]propanediol. This substance is an enantiomer of pantoprazole, which has been determined to be inactive. Pantoprazole impurity can be identified by its melting point, crystallizing habit, and optical rotation. Active carbon filtration can be used to remove this substance from the final product.</p>Fórmula:C24H24F2N4O5SPureza:Min. 95%Peso molecular:518.53 g/mol3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-7,8-dihydro-2-methyl-4H-pyrido[1,2-a]pyrimidine-4,9(6H)-dione
CAS:<p>3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-7,8-dihydro-2-methyl-4H-pyrido[1,2-a]pyrimidine-4,9(6H)-dione is a research and development impurity standard. It is a synthetic drug product with high purity and pharmacopoeia grade. 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1 piperidinyl]ethyl]-7,8 dihydro 2 methyl 4 H pyrido [ 1 , 2 - a ] pyrimidine 4 9 ( 6 H ) dione has CAS No. 118951665 1 and is an analytical standard for HPLC analysis. 3-[2-[4-(6 Fluoro 1 , 2 benzisox</p>Fórmula:C23H25FN4O3Pureza:Min. 95%Peso molecular:424.47 g/mol3-[2-[4-(1,2-Benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
CAS:<p>3-[2-[4-(1,2-Benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one is an analog of the antibacterial drug cefuroxime. It has been shown to be a potent inhibitor of bacterial DNA gyrase and topoisomerase IV. This compound has been shown to have a greater degree of activity against Gram Positive bacteria than Gram Negative bacteria in vitro. 3-[2-[4-(1,2-Benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-- 2 -methyl-- 4H-- pyrido[1,2-- a]pyrimidin-- 4 -one is not active against acid</p>Fórmula:C23H28N4O2Pureza:Min. 95%Peso molecular:392.49 g/molSolifenacin EP impurity F succinate
CAS:<p>Solifenacin is an anti-cholinergic drug that has been shown to have a potent antagonistic effect on muscarinic receptors. It is used in the treatment of overactive bladder, urinary incontinence, and irritable bowel syndrome. Solifenacin succinate is a metabolite of solifenacin and it has been found to be an antagonist of M3 muscarinic receptors. The presence of solifenacin and its metabolites in wastewater can interfere with treatment processes by inhibiting the removal of other organic chemicals such as tamsulosin hydrochloride. Optimisation studies for solifenacin production have shown that famotidine can be used as a process aid to reduce solifenacin impurities. Famotidine is also an antagonist of M3 muscarinic receptors and can be used to remove solifenacin from wastewater. Analytes detected in wastewater samples include solifenacin, famot</p>Fórmula:C27H32N2O6Pureza:Min. 95%Peso molecular:480.55 g/molN-Formyl Saxagliptin
<p>N-Formyl Saxagliptin is an analytical standard for HPLC. It is used as a drug development and API impurity in the pharmaceutical industry. It was synthesized by reacting formaldehyde with the amino acid L-glutamic acid, followed by purification to remove any other contaminants. The CAS number for this chemical is 57847-82-0.</p>Pureza:Min. 95%Losartan azide
CAS:<p>Please enquire for more information about Losartan azide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C22H22ClN9Pureza:Min. 95%Peso molecular:447.93 g/molChlorhexidine diacetate impurity A
CAS:<p>Chlorhexidine diacetate impurity A is a high purity, analytical standard for the detection of chlorhexidine diacetate impurities in drug products. Chlorhexidine diacetate impurity A is a natural metabolite that is produced by the metabolism of chlorhexidine diacetate. It has been shown to be a potential biomarker for assessing the metabolism of chlorhexidine diacetate and has also been shown to have antimicrobial activity against bacteria, fungi and yeast.</p>Fórmula:C16H24ClN9Pureza:Min. 95%Cor e Forma:White to off-white solid.Peso molecular:377.88 g/molSalbutamol EP impurity C
CAS:<p>Salbutamol EP Impurity C is an impurity of Salbutamol EP, which is an active pharmaceutical ingredient. It is a hydrophilic interaction chromatography and reverse-phase high-performance liquid chromatography method that can be used to screen for the presence of impurities in this product. The detection method is based on the use of a diode array detector with a synchronous detection mode. The column used in this screening process is a liquid chromatography column with a particle size of 5 microns and a length of 250 mm, which has been packed with 5% phenyl-95% dimethyl polysiloxane stationary phase. This process requires acetonitrile as the mobile phase, and the detection wavelength ranges from 220 nm to 240 nm.</p>Fórmula:C13H21NO2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:223.31 g/mol3-(Dimethylamino)-1-(2-thienyl)propanone hydrochloride
CAS:<p>3-(Dimethylamino)-1-(2-thienyl)propanone hydrochloride is a sulfoxide that is used as a solvent. It has been used in the synthesis of benzylsulfoxides and solvents for the manufacture of pharmaceuticals. 3-(Dimethylamino)-1-(2-thienyl)propanone hydrochloride is also a potent compound, which is structurally similar to benzene but with an additional methyl group. 3-(Dimethylamino)-1-(2-thienyl)propanone hydrochloride has been used in the synthesis of melphalan and elemental analysis. The chloride group on its structure makes it soluble in water and organic solvents such as acetonitrile. 3-(Dimethylamino)-1-(2-thienyl)propanone hydrochloride can be synthesized by reacting nitric acid with 2-aminothiophenol and dimethylanil</p>Fórmula:C9H14ClNOSPureza:Min. 95%Peso molecular:219.73 g/molDeiodo amiodarone
CAS:<p>Deiodo amiodarone is a noncompetitive inhibitor that binds to the active site of the enzyme and blocks the binding of substrate, thereby inhibiting the synthesis of catecholamines. Deiodo amiodarone has been shown to inhibit the oxidation of benzofuran derivatives in rat liver microsomes, human liver tissue samples, and chromatographic conditions. The inhibition constant for deiodo amiodarone was determined by liquid chromatography with a homogenizing technique.</p>Fórmula:C25H30INO3Pureza:Min. 95%Peso molecular:519.42 g/mol(S)-3-(Dimethylamino)-1-(2-thienyl)propan-1-ol
CAS:<p>(S)-3-(Dimethylamino)-1-(2-thienyl)propan-1-ol is a polymerase chain reaction (PCR) reagent that is used as a building block for the synthesis of five membered ring lactams and dihedral polymers. This compound is synthesized by chemoenzymatic coupling of propanamine with trifluoroacetic acid in the presence of methyl groups, followed by catalytic hydrogenation to yield the desired product. The asymmetric synthesis of this compound was achieved through chiral resolution using NMR spectroscopy.</p>Fórmula:C9H15NOSPureza:Min. 95%Peso molecular:185.29 g/mol5-O-Desethyl amlodipine
CAS:<p>5-O-Desethyl amlodipine is a metabolite of amlodipine. It has been used as an analytical reference standard for the determination of amlodipine and its metabolites in human plasma and urine. 5-O-Desethyl amlodipine has been reported to be excreted in human breast milk at a concentration that is about 20% of that found in maternal plasma. The drug product is manufactured by HPLC and is classified as a high purity pharmaceutical drug, which means it is free from extraneous substances such as other drugs, proteins, or bacteria.</p>Fórmula:C18H21ClN2O5Pureza:Min. 95%Peso molecular:380.82 g/mol(3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine
CAS:<p>Granisetron is a drug that belongs to the group of serotonin receptor antagonists. It is used as an antiemetic, mainly in the prevention and treatment of nausea and vomiting caused by cancer chemotherapy and surgery. This drug has been shown to be effective in controlling nausea and vomiting, even when given after chemotherapy or surgical procedures. Granisetron hydrochloride was synthesized in 1988 by chemists at Hoffmann-La Roche. The synthesis was patented in 1990. Potential impurities are not listed on the USP or EP pharmacopeia, but these impurities have been detected during synthesis.</p>Fórmula:C9H18N2Pureza:Min. 95%Peso molecular:154.25 g/molPantoprazole N-oxide
CAS:<p>Pantoprazole is a proton pump inhibitor that inhibits the gastric acid secretion by blocking the hydrogen/potassium ATPase enzyme in the stomach. Pantoprazole N-oxide, a prodrug of pantoprazole, is converted to pantoprazole after administration and has been shown to be more stable than pantoprazole. It has been shown to have tissue-specific effects, with high concentrations found in gastrointestinal tissues such as the abomasum, ileum, and colon. Pantoprazole N-oxide is also found in plasma samples at low levels. This drug may be useful for ulceration because it prevents heartburn caused by excess stomach acid.</p>Fórmula:C16H15F2N3O5SPureza:Min. 95%Cor e Forma:PowderPeso molecular:399.37 g/molSolifenacin N-oxide
CAS:<p>Solifenacin N-oxide is an anti-cholinergic agent that has been shown to be effective in the treatment of overactive bladder. Solifenacin N-oxide is a prodrug that is hydrolyzed in vivo to solifenacin, its active form. The compound reversibly binds to muscarinic receptors and inhibits the release of acetylcholine. Solifenacin N-oxide has been shown to have low levels of impurities and is highly soluble in water. It was also found to be stable when stored at room temperature for two months. This drug has a high flow rate and moderate retention time, which makes it suitable for reversed-phase liquid chromatography (RPLC). RPLC is a chromatographic technique that separates compounds by size, hydrophobicity, or charge.</p>Fórmula:C23H26N2O3Pureza:Min. 95%Cor e Forma:White PowderPeso molecular:378.46 g/mol1-[(1-Methylethyl)amino]-3-phenoxy-2-propanol
CAS:<p>1-[(1-Methylethyl)amino]-3-phenoxy-2-propanol is an organic compound that belongs to the class of phenoxyethanol derivatives. It has been used in milligram amounts to assist in the separation of racemic mixtures by countercurrent chromatography. The compound is a racemate and the enantiomers are separated by chiral high performance liquid chromatography. The β-adrenergic agonist activity of 1-[(1-methylethyl)amino]-3-phenoxy-2-propanol has been shown in rats.</p>Fórmula:C12H19NO2Pureza:Min. 95%Peso molecular:209.28 g/mol(R,R)-Solifenacin succinate
CAS:<p>(R,R)-Solifenacin succinate is a pharmaceutical agent that acts as an antimuscarinic drug. It has been shown to be effective in wastewater treatment, where it was found to reduce the amount of solifenacin and optimised organic chemicals in the water. This drug has also been shown to have antagonist properties against the muscarinic receptor M3.</p>Fórmula:C23H26N2O2•C4H6O4Pureza:Min. 95%Cor e Forma:PowderPeso molecular:480.55 g/molDutasteride EP impurity E
CAS:<p>Please enquire for more information about Dutasteride EP impurity E including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C27H30F6N2O2Pureza:Min. 95%Peso molecular:528.54 g/mol3,4-Dimethoxyphenyl isopropyl ketone
CAS:<p>3,4-Dimethoxyphenyl isopropyl ketone (DMPK) is a calcium antagonist that has been shown to be hypotensive in rats. It is also used as a pharmacological agent to study muscle physiology and biotransformations. DMPK has been shown to have microbial uptake and chronotropic properties, which may explain its use in the treatment of bacterial infections. DMPK binds to sulfoxides and chiral compounds, blocking their activity by inhibiting the enzyme systems involved in oxidation reactions. The drug is an analog of benzyl alcohol, with which it shares similar pharmacological profile.</p>Fórmula:C12H16O3Pureza:Min. 95%Peso molecular:208.25 g/mol9,10-Dioxo ketotifen
CAS:<p>9,10-Dioxo ketotifen is a drug product that belongs to the category of HPLC standards. It has been shown to be a metabolite of ketotifen and also an impurity in ketotifen. 9,10-Dioxo ketotifen has been shown to possess antihistamine activity and may have potential as a lead compound for the development of new drugs.</p>Fórmula:C19H17NO2SPureza:Min. 95%Cor e Forma:PowderPeso molecular:323.41 g/molThiamethoxam
CAS:<p>Thiamethoxam ((E)-thiamethoxam) is an insecticide of broad-spectrum neonicotinoids.</p>Fórmula:C8H10ClN5O3SPureza:>99.99%Cor e Forma:SolidPeso molecular:291.712-((2-Methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetic acid
CAS:<p>2-((2-Methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetic acid (KZPBA) is a zoonotic antibiotic that has been shown to be active against agalactiae. It is a prodrug, which is metabolized to the active form, KZPBA, in humans and other mammals. The mechanism of action of KZPBA is not yet known; however, it has been hypothesized that its activity may be due to inhibition of DNA gyrase and topoisomerase IV. This drug has also been shown to have an effect on mastitis in dairy cows.</p>Fórmula:C19H29O6PPureza:Min. 95%Peso molecular:384.4 g/molLosartan isomer impurity, potassium salt
CAS:Produto Controlado<p>Losartan is an angiotensin II receptor antagonist. It is used in the treatment of hypertension to reduce blood pressure and improve symptoms of heart failure. Losartan is used as a drug product and impurity standard for the pharmaceutical industry, specifically for its metabolite, losartan isomer impurity, potassium salt (CAS No. 860644-28-6). This compound is a white crystalline powder that can be custom synthesized or obtained from natural sources. High purity Losartan Isomer Impurity, Potassium Salt (CAS No. 860644-28-6) can be purchased from specialty suppliers such as Sigma Aldrich and Acros Organics.</p>Fórmula:C22H22ClKN6OPureza:Min. 95%Peso molecular:461 g/molChloromethyl olanzapinium chloride
CAS:<p>Chloromethyl olanzapinium chloride is an analytical reference material that can be used as a standard for HPLC-UV analysis. It is also used in the development of new drugs and as an impurity standard during drug manufacturing. Chloromethyl olanzapinium chloride has been shown to be a metabolite of Olanzapine, which is a niche drug product that is not commercially available. Chloromethyl olanzapinium chloride is listed by the USP, EP and JP as a drug product impurity. It can be synthesized from natural or synthetic sources.</p>Fórmula:C18H22Cl2N4SPureza:Min. 95%Cor e Forma:PowderPeso molecular:397.37 g/molRisperidone E-oxime impurity
CAS:<p>Risperidone E-oxime impurity is a drug product that has been studied for its metabolism in humans, animals and plants. It is an analytical standard that is used as an impurity in the synthesis of risperidone. Risperidone E-oxime impurity is also a synthetic compound with CAS No. 691007-09-7. It can be used as a pharmacopoeia high purity HPLC standard and as a research and development synthetic compound.</p>Fórmula:C23H28F2N4O2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:430.49 g/molN2-Methyl alfuzosin hydrochloride (1:1)
CAS:<p>N2-Methyl alfuzosin hydrochloride (1:1) is a synthetic compound that is used as an impurity standard for the drug product Alfuzosin. It has been shown to be metabolized by the liver, and its metabolites are excreted through the bile. The N2-methyl group of this compound provides a marker for metabolism studies and it has been shown to inhibit bacterial growth in vitro.</p>Fórmula:C19H28ClN5O4Pureza:Min. 95%Peso molecular:425.91 g/mol[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl](4-hydroxyphenyl)-methanone
CAS:<p>MDM2 inhibitors are a class of cancer drugs that inhibit the activity of MDM2, which is an oncoprotein that prevents the degradation of p53. This inhibition leads to increased levels of p53 and the activation of its tumor-suppressing functions. The anti-cancer activity of this drug has been shown in a number of cancer cells, including human colon cancer cells, human prostate cancer cells, and murine leukemia cells. Furthermore, this drug has been shown to have synergistic effects when combined with other chemotherapeutic agents such as cisplatin and vincristine.</p>Fórmula:C21H14O4SPureza:Min. 95%Peso molecular:362.4 g/molChlorhexidine dihydrochloride impurity B
CAS:<p>Chlorhexidine dihydrochloride impurity B is an impurity found in chlorhexidine dihydrochloride, a drug that is used as an antiseptic and disinfectant. It is a metabolite of chlorhexidine and has been detected in urine and plasma samples. This impurity has no known pharmacological activity. The purity of this compound is not less than 99%.</p>Fórmula:C16H28Cl3N9OPureza:Min. 95%Cor e Forma:White PowderPeso molecular:468.81 g/mol2-[[2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione
CAS:<p>Please enquire for more information about 2-[[2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C22H19N3O6Pureza:Min. 95%Peso molecular:421.4 g/mol1-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]-1H-benzi midazole
CAS:<p>1-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]-1H-benzi midazole is a high purity analytical standard that is used to calibrate HPLC. It is found as an impurity in the drug product and as a metabolite. 1-[(3-Methyl-4-(2,2,2 -trifluoroethoxy) - 2 - pyridinyl) methyl] - 2 - [[[3 - methyl (4 ( 2 , 2 , 2 - trifluoroethoxy) - 2 pyridinyl) methyl] thio] - 1 H benzimidazole is the IUPAC name for this compound. This chemical has been synthesized</p>Fórmula:C25H22F6N4O2SPureza:Min. 95%Peso molecular:556.52 g/molValdecoxib 3'-sulfonamide
CAS:<p>Valdecoxib 3'-sulfonamide is a synthetic, non-naturally occurring drug product that has been custom synthesized for the purposes of research and development. It is not a natural API nor is it an impurity standard. This compound has been developed as a new lead compound for pharmacological studies and drug development, with an emphasis on high purity standards. The CAS number for this compound is 1373038-56-2.</p>Fórmula:C16H14N2O3SPureza:Min. 95%Peso molecular:314.36 g/molDe(diethylaminoethyl-5-iodo) Amiodarone
CAS:<p>Amiodarone is a drug that belongs to the group of annular compounds. It has been used in the treatment of cardiac arrhythmias, such as atrial fibrillation (AF) and ventricular tachycardia (VT). Amiodarone has been shown to have a high affinity for specific genes, including those involved in the regulation of the heart. This drug is also used in animals, such as dogs and rats. Amiodarone has been shown to have toxic effects on cardiac tissue and other organs, which may be due to its ability to inhibit the metabolism of thyroid hormones by deiodination. Amiodarone also inhibits synthesis of protein by binding to DNA, inhibiting transcription and translation.</p>Fórmula:C19H17IO3Pureza:Min. 95%Cor e Forma:PowderPeso molecular:420.24 g/mol5-Dimethylaminobutyryl citalopram
CAS:<p>5-Dimethylaminobutyryl citalopram is a metabolite of the antidepressant drug, Citalopram. It is used as an analytical impurity standard for Citalopram in HPLC and LCMS analysis. 5-Dimethylaminobutyryl citalopram is also a natural product of metabolism and may be found in humans. 5-Dimethylaminobutyryl citalopram has been shown to have similar pharmacological properties to Citalopram in animal studies, which include antihistamine effects and analgesic effects. This compound may be useful as a niche treatment for some patients who are resistant to other drugs.</p>Fórmula:C25H33FN2O2Pureza:Min. 95%Peso molecular:412.54 g/mol3-[2-[4-(6-Fluoro-2-benzoxazolyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
CAS:<p>3-[2-[4-(6-Fluoro-2-benzoxazolyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one is a synthetic compound that functions as a drug product. It is not found in nature and has been synthesized for use as an API impurity. The CAS number for this compound is 1005191-81-0. 3-[2-[4-(6-Fluoro-2 -benzoxazolyl)-1 -piperidinyl]ethyl]-6,7,8,9 tetrahydro 2 methyl 4H pyrido 1 2 a pyrimidin 4 one has been studied in metabolism studies. It is also known to have niche applications in analytical chemistry and research and development.</p>Fórmula:C23H27FN4O2Pureza:Min. 95%Peso molecular:410.48 g/molSolifenacin Impurity D
CAS:<p>Solifenacin Impurity D is a synthetic impurity of solifenacin. Solifenacin is an anti-cholinergic drug used to treat overactive bladder and urinary incontinence. The purity of this product is 99%. It is soluble in methanol, ethanol, chloroform, and acetone. Solifenacin Impurity D can be used as a reference material for analytical purposes or as an impurity standard in the development of new drugs.</p>Fórmula:C31H28N2OPureza:Min. 96 Area-%Cor e Forma:White PowderPeso molecular:444.57 g/molCyamemazine sulfoxide
CAS:<p>Cyamemazine sulfoxide is a histamine H1 receptor antagonist. It has been shown to have strong affinity for the serotonin 5-HT2C and dopamine D2 receptors, as well as the atrial 5-HT2A receptors. Cyamemazine sulfoxide has a low oral bioavailability of about 10% and is metabolized in the liver to cyamemazine and its active form, cyamemazine sulfoxide. Cyamemazine sulfoxide binds to serotonin 5-HT2C receptors with a high affinity, which leads to inhibition of serotonin release from nerve endings in the brain. This drug also inhibits dopamine release from nerve endings in the brain and has been shown to have cardiac effects on heart rate and contractility.</p>Fórmula:C19H21N3OSPureza:Min. 95%Peso molecular:339.46 g/molDasatinib impurity
CAS:<p>Dasatinib is a cancer drug that is used to treat patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It inhibits the activity of tyrosine kinases, in particular Bcr-Abl and Src. Dasatinib is a structural analog of imatinib, which has been shown to be effective against chronic myeloid leukemia by inhibiting the activity of Bcr-Abl. Dasatinib impurity is an unwanted substance found in dasatinib. It can be synthesized from formic acid, chloride and chlorine using a series of industrial processes. The salt form of dasatinib impurity is acidic and synthetic.</p>Fórmula:C22H27N7O2SPureza:Min. 95%Peso molecular:453.56 g/molN-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
CAS:<p>N-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine (GW1929) is a potent vasodilator that is used for the treatment of hypertension. It is synthesized by condensation of sodium hydroxide with 2-(4′-chlorophenyl)piperazine followed by methyl esterification and chloride acylation. The synthesis of GW1929 has been accomplished in two steps: carbonate cyclization and valsartan hydrolysis. In the first step, the carboxylic acid group of GW1929 was converted to its corresponding chloride compound which was then reacted with methyl bromide to yield the desired product. The second step involved hydrolysis of GW1929 with potassium carbonate, after which it was oxidized with azide to form an ester. Sodium</p>Fórmula:C23H27N5O3Pureza:Min. 95%Cor e Forma:White PowderPeso molecular:421.49 g/molAnastrozole dimer impurity
CAS:<p>Anastrozole is an aromatase inhibitor that has been used in the treatment of breast cancer. It binds competitively to the heme moiety of aromatase, blocking its access to substrate and thereby inhibiting estrogen production. Anastrozole dimer impurity is an analytical impurity found in drug products that is not a natural component of the API (active pharmaceutical ingredient). CAS No. 1216898-82-6 refers to this impurity standard as well as other synthetic analogues. This impurity is a custom synthesis with no pharmacopoeia standards for purity. The HPLC standard for this product is high purity (99%).</p>Fórmula:C30H31N9Pureza:Min. 95%Peso molecular:517.63 g/mol1-Isopropyl-1-N-methylpropylamino-(3,4-dimethoxyphenyl)acetonitrile
CAS:<p>1-Isopropyl-1-N-methylpropylamino-(3,4-dimethoxyphenyl)acetonitrile is a fluorescent probe that can be used for the detection of drugs in biological samples. It has been shown to have a high fluorescence intensity and low detection sensitivity, making it suitable for use as a probe for detecting drugs with low concentrations. This probe can also be used to study drug interactions and its concentration–time curve in humans. The drug transporter P-glycoprotein (Pgp) is inhibited by verapamil, which could explain the increase in 1-isopropyl-1-N-methylpropylamino-(3,4-dimethoxyphenyl)acetonitrile's detection sensitivity.</p>Fórmula:C17H26N2O2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:290.4 g/mol3-[(1E)-2-[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]diazenyl] balsalazide
CAS:<p>3-[(1E)-2-[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]diazenyl] balsalazide is a white to off-white solid that is soluble in water and acidic solutions. It has an impurity level of less than 0.5%. The melting point of 3-[(1E)-2-[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]diazenyl] balsalazide is approximately 195°C. This compound has been shown to have antibiotic activity against a variety of bacteria, including methicillin resistant Staphylococcus aureus (MRSA).</p>Fórmula:C27H24N6O9Pureza:Min. 95%Peso molecular:576.51 g/mol2-[3-[4-(3-Chloro-4-ethylphenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one
CAS:<p>2-[3-[4-(3-Chloro-4-ethylphenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one is a research and development impurity standard. Impurities are the substances that are not intentionally added to the drug product but can be generated from the synthesis process or from the raw materials. This substance has been used as a synthetic intermediate in the production of other drugs and as an analytical reference for HPLC analysis. It is used to help develop new drugs by providing data about metabolites and possible toxic effects on humans.</p>Pureza:Min. 95%Rivaroxaban impurity 79
CAS:<p>Please enquire for more information about Rivaroxaban impurity 79 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C38H38N4O12Pureza:Min. 95%Peso molecular:742.74 g/molOmeprazole Impurity 65
<p>Impurity 65 is an impurity of Omeprazole, a drug used to treat gastroesophageal reflux disease and peptic ulcer. Impurity 65 is a metabolite of Omeprazole that can be found in the drug product at a concentration up to 0.5%. It has been shown to have anti-inflammatory effects and can be used as a research and development standard for HPLC analysis. Impurity 65 is also used as an impurity standard in the USP pharmacopoeia and other pharmacopoeias around the world.</p>Fórmula:C17H17N3O4Pureza:Min. 95%Peso molecular:327.33 g/mol5-Chloro-N-[3-[[(5-chloro-2-thienyl)carbonyl]amino]-2-hydroxypropyl]-N-[4-(3-oxo-4-morpholinyl)phenyl]-2-thiophenecarboxamide
CAS:<p>Please enquire for more information about 5-Chloro-N-[3-[[(5-chloro-2-thienyl)carbonyl]amino]-2-hydroxypropyl]-N-[4-(3-oxo-4-morpholinyl)phenyl]-2-thiophenecarboxamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C23H21Cl2N3O5S2Pureza:Min. 95%Peso molecular:554.47 g/molTadalafil spiro-urethane impurity (EP impurity F)
CAS:<p>Please enquire for more information about Tadalafil spiro-urethane impurity (EP impurity F) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C22H19N3O6Pureza:Min. 95%Peso molecular:421.4 g/molLansoprazole impurity H
CAS:<p>Lansoprazole impurity H is a metabolite of lansoprazole, a proton pump inhibitor that inhibits the production of stomach acid. Lansoprazole impurity H is used in research and development as an analytical standard to measure lansoprazole concentrations in drug products. It is also used as an impurity standard for pharmacopoeia purposes. Lansoprazole impurity H is not known to be toxic, but it has not been evaluated for carcinogenicity or reproductive toxicity.</p>Fórmula:C23H16F3N5OSPureza:90%MinPeso molecular:467.47 g/molSalbutamol EP Impurity F
CAS:<p>Salbutamol EP Impurity F is a drug impurity that is an analytical standard and pharmacopoeia reference material. It is used in the manufacture of pharmaceuticals to ensure that the product meets quality standards. Salbutamol EP Impurity F has been shown to be a metabolite of salbutamol, which is produced as a result of oxidative metabolism by cytochrome P450 enzymes such as CYP3A4. The compound has also been observed in human urine and plasma.</p>Fórmula:C26H40N2O5Pureza:Min. 95%Peso molecular:460.61 g/mol3’-Destrifluoromethyl 2’-trifluoromethyl cinacalcet
CAS:<p>3' - Destrifluoromethyl 2' - trifluoromethyl cinacalcet is a metabolite of cinacalcet, which is a drug used for the treatment of secondary hyperparathyroidism. It is an impurity in the drug product and can be identified by HPLC.</p>Fórmula:C22H22F3NPureza:Min. 95%Peso molecular:357.41 g/molrac-Des(isopropylamino) acebutolol diol
CAS:<p>rac-Des(isopropylamino) acebutolol diol is a synthetic drug substance that is used for research and development purposes. It has a purity of 99% or greater, does not contain any impurities, and is manufactured using the latest technology. The rac-Des(isopropylamino) acebutolol diol is a pharmaceutical grade product with high purity and quality standards that have been verified by HPLC analysis. This compound is an analytical standard that can be used to calibrate mass spectrometry instruments. Rac-Des(isopropylamino) acebutolol diol is also metabolized into the natural metabolite noracebutanol by cytochrome P450 enzymes in humans.</p>Fórmula:C15H21NO5Pureza:Min. 95%Peso molecular:295.33 g/molDechloro anagrelide
CAS:<p>Dechloro anagrelide is a synthetic product that has been developed for use in drug development. It is a white powder and is insoluble in water. Dechloro anagrelide is used as a reference standard for the analysis of impurities found in anagrelide. This product is also used for HPLC analyses and research and development purposes.</p>Fórmula:C10H8ClNO3Pureza:Min. 95%Peso molecular:225.63 g/mol[4-(4-Amino-7-hydroxy-6-methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)-methanone
CAS:<p>3-amino-2,6-dimethoxy-4-(4-amino-7-hydroxy-6-methoxyquinazolin-2(1H)-yl)piperazine (DMQA) is a synthetic compound. It is a racemate with two stereoisomers, which are mirror images of each other. The two stereoisomers have been characterized and the data for the two stereoisomers are provided in the table below.</p>Fórmula:C18H23N5O4Pureza:Min. 95%Peso molecular:373.41 g/molAlverine EP Impurity C
CAS:<p>Alverine EP Impurity C is a by-product of the synthesis of alverine, which is an ammonium salt. The process involves the use of high yield, high purity triflic acid, and organic solvents. The reaction system is typically carried out in a solvent such as toluene or dichloromethane. The organic solvent is then removed by filtration and the desired product can be obtained by crystallization or recrystallization. Alverine EP Impurity C has been shown to have insecticidal properties when applied externally, due to its interaction with insect stereoisomers. It also has anticancer activity and may be used in cancer therapy treatments that involve decompressing tumours and increasing blood supply to the area. Alverine EP Impurity C also has a citric acid binding property that makes it insoluble in water.</p>Fórmula:C11H17NPureza:Min. 95%Peso molecular:163.26 g/molEthyl 2-(6-amino-2,3-dichlorobenzyl)glycine
CAS:<p>Ethyl 2-(6-amino-2,3-dichlorobenzyl)glycine is a drug product with a CAS number of 70406-92-7. It has an analytical purity of greater than 98% and is supplied as a white powder. This product is metabolized in the human body to form an active metabolite. The chemical name for this drug product is ethyl 2-(6-amino-2,3-dichlorobenzyl)glycine, which can be found in the pharmacopoeia under the name of 6′ amino 2,3′ dichlorobenzyl glycine.</p>Fórmula:C11H14Cl2N2O2Pureza:Min. 95%Peso molecular:277.15 g/mol2-Amino-5,6-dichloro-3,4-dihydroquinazoline hydrobromide
CAS:<p>2-Amino-5,6-dichloro-3,4-dihydroquinazoline hydrobromide is a metabolite of the drug product 2-[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)ethylamino]benzeneacetic acid. It has been shown to inhibit protein synthesis in vitro and in vivo.</p>Fórmula:C8H8BrCl2N3Pureza:Min. 95%Peso molecular:296.98 g/mol((3R,5S,6E)-Methyl-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin -3-yl)-3,5-dihydroxyhept-6-enoate
CAS:<p>((3R,5S,6E)-Methyl-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin -3-yl)-3,5-dihydroxyhept-6-enoate is a metabolite of the drug product. It is a white to off-white crystalline powder that is soluble in methanol and insoluble in water. This compound has been shown to be an impurity standard for HPLC analysis of the drug product. ((3R,5S,6E)-Methyl-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin -3-yl)-3,5-dihydroxyhept-6-enoate has been used in metabolism studies and pharmacopoeia as a reference substance for the analytical testing of drugs. It can also be synthesized for research purposes.</p>Pureza:Min. 95%Trazodone Hydrochloride BP Impurity A
CAS:<p>Trazodone Hydrochloride BP Impurity A is an unproven impurity of Trazodone. It inhibits the uptake of serotonin by 5-HT receptors, which may be important in the treatment of depression. This compound also inhibits platelet aggregation and has been found to inhibit the activity of tricyclic compounds, such as piperazine and propionic acid.</p>Fórmula:C19H22CIN5O2Pureza:Min. 95%Peso molecular:491.33 g/mol6,7,8,9-Tetrahydro-3-[2-[4-(6-methoxy-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
CAS:<p>A custom synthesis of 6,7,8,9-tetrahydro-3-[2-[4-(6-methoxy-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-4H-[1]pyrido[1,2-a]pyrimidin-4one<br>A synthetic analog of the natural product erythromycin A.<br>Metabolite: 3-[2-[4-(6-Methoxybenzo[d][1,3]dioxol-5(4H)-yl)-1piperidinyl)ethyl]-6,7,8,9 tetrahydro 4H pyrido [1',2' a] pyrimidin 4 one<br>Impurity: 1-(6 methoxy benzisoxazol 3 yl) piperidine<br>Custom synthesis: yes<br>High purity: yes</p>Fórmula:C24H30N4O3Pureza:Min. 95%Peso molecular:422.52 g/mola-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-propyl-benzeneacetonitrile
CAS:<p>a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-propyl-benzeneacetonitrile is a drug product that is custom synthesized and has been shown to have high purity. It is also used in analytical studies, metabolism studies, and natural drug development. This compound can also be found as an impurity standard for HPLC or as an API impurity.</p>Fórmula:C27H38N2O4Pureza:Min. 95%Peso molecular:454.6 g/mol2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine]
CAS:<p>2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine] is a chemical compound that is used as a lead to develop new drugs against malaria. It inhibits the growth of plasmodium falciparum and has been shown to be active in high-throughput screening assays. 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine] may serve as an active molecule for the treatment of malaria in combination with other antiplasmodial agents. The drug discovery process prioritized this compound because it is an asexual stage inhibitor and has gametocyte inhibitory activities.</p>Fórmula:C24H28N8O4Pureza:Min. 95%Peso molecular:492.53 g/molCaptopril EP Impurity H
CAS:<p>Captopril EP Impurity H is a drug product that is used as an analytical reference standard. It is not intended for administration to humans or animals. Captopril EP Impurity H is manufactured by the same process as Captopril, but with a different impurity profile. The purity of this product is 99.5% at 25°C, and it has an impurity profile of less than 0.5%. This product is also known as 4-Amino-N-(2,6-dichlorophenyl)benzenesulfonamide and has CAS No. 205521-07-9.</p>Fórmula:C15H23NO5S2Pureza:Min. 95%Peso molecular:361.48 g/molAlverine EP Impurity E
CAS:<p>Alverine EP Impurity E is a nitrogen containing compound with the molecular formula C9H10N. It has been shown to be an ionophore, which means that it can transport ions across a membrane. Alverine EP Impurity E is stabilized by alkali and buffered with a pH range of 7-8. The response time for this compound is linear and its contact time ranges from 1-12 hours. This impurity has a phenyl group and a ph range of 6-7. It reacts with electrodes in an electrical field, forming an electric current when it comes into contact with the electrodes. The nitrogen atom in Alverine EP Impurity E is bonded to two carbon atoms and one hydrogen atom.</p>Fórmula:C27H33NPureza:Min. 95%Peso molecular:371.56 g/mol2-[[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane
CAS:<p>2-[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]methyloxirane is a metabolite of the drug product 2-[[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane. It is an impurity in the drug product, which is a pharmaceutical intermediate that has been shown to have pharmacological properties. The CAS number for this compound is 63659-17-6 and it has been assigned the Chemical Abstracts Service (CAS) number of 63659-17-6. This compound has been characterized using HPLC and GC/MS methods.</p>Fórmula:C15H20O3Pureza:Min. 95%Peso molecular:248.32 g/molN-Hydroxy-6-(trifluoromethoxy)-2-benzothiazolamine
CAS:<p>N-Hydroxy-6-(trifluoromethoxy)-2-benzothiazolamine (NHTB) is a drug that has been shown to have clinical use as an anticonvulsant. NHTB is a metabolite of diazepam, which is used to treat seizures and anxiety. It binds to the GABA receptor and increases the duration of time that the chloride channel remains open, leading to inhibition of neural activity and in turn seizure control. NHTB has been found to be more potent than diazepam and has also been shown to bind to other receptors, such as dopamine receptors.</p>Fórmula:C8H5F3N2O2SPureza:Min. 95%Peso molecular:250.2 g/mol[1,1'-Biphenyl]-2'-(2H-tetrazol-5-yl)-4-carboxylic acid, [1,1'-biphenyl]-(2'-(2H-tetrazol-5-yl)-4-yl)methyl ester
CAS:<p>Biphenyl-2'-(2H-tetrazol-5-yl)-4-carboxylic acid, [1,1'-biphenyl]-(2'-(2H-tetrazol-5-yl)-4-yl)methyl ester is a research and development impurity standard. It is a synthetic compound that can be custom synthesized to meet your needs. The product is available in high purity and pharmacopoeia grade. It has been used as a drug product in studies involving metabolism of the drug. This product has also been used as an analytical standard for HPLC analysis.</p>Fórmula:C28H20N8O2Pureza:Min. 95%Peso molecular:500.51 g/molDesdifluoromethoxy hydroxy pantoprazole
CAS:<p>Desdifluoromethoxy hydroxy pantoprazole is a synthetic compound that is used as an impurity standard for the drug product Pantoprazole. It has a purity of ≥98% and is stable under ambient conditions. Desdifluoromethoxy hydroxy pantoprazole is not active on its own, but it is a metabolite of pantoprazole. It can be used to study the metabolism of pantoprazole.</p>Fórmula:C15H15N3O4SPureza:Min. 95%Peso molecular:333.36 g/molCinacalcet impurity E hydrochloride
CAS:<p>Cinacalcet is a drug product that is used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. It is metabolized through a number of metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. The high frequency of human activity has been shown using a patch-clamp technique on human erythrocytes. Cinacalcet impurity E hydrochloride (CIN-E) is an analytical standard for use in HPLC as an impurity of cinacalcet. This compound has not been found to be pharmacologically active and its effects are unknown.</p>Fórmula:C22H25N·HClPureza:Min. 95%Peso molecular:339.9 g/molPhenobarbital impurity A
CAS:<p>Phenobarbital impurity A is a drug product that can be synthesized by Custom synthesis, and is available in high purity. It has been used for metabolic studies and as an analytical standard. Phenobarbital impurity A is a metabolite of phenobarbital, which is a natural drug, and has been used in the development of drugs and pharmaceuticals. This impurity has also been used as a pharmacopoeia standard and as a research and development reagent. CAS No. 69125-70-8</p>Fórmula:C12H14N4OPureza:Min. 95%Cor e Forma:PowderPeso molecular:230.27 g/mol(2R)-2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-isopropylpentanenitrile hydrochloride
CAS:<p>(2R)-2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-isopropylpentanenitrile hydrochloride (ZD4054) is a drug that has been shown to be sensitive to the efflux pump in Escherichia coli. It is also able to inhibit multidrug resistance in nematodes and cross-resistance in humans. ZD4054 inhibits multidrug resistance by inhibiting the efflux of drugs from cells. This prevents the development of resistance to antibiotics and other drugs. The mechanism of action for this drug is unknown, but it may affect chloride channels that are found on the cell membrane. ZD4054 has also been shown to be effective against C.elegans and Drosophila melanogaster, two species commonly used for research purposes.</p>Fórmula:C27H39ClN2O4Pureza:Min. 95%Peso molecular:491.06 g/molRegorafenib metabolite M2 oxide
CAS:<p>Regorafenib metabolite M2 oxide (M2O) is a cancer drug that is an inhibitor of multikinase. It was developed as a prodrug for regorafenib, which is used to treat patients with metastatic colorectal cancer and has been shown to be effective against other cancers, such as lung and pancreatic cancer. M2O inhibits the efflux of drugs from cells by binding to the transporter protein P-glycoprotein. This prevents the accumulation of toxic concentrations of regorafenib in cells, which are responsible for its side effects, such as diarrhea and liver damage. The uptake of M2O by cells is also inhibited by light and acidic conditions. Oral administration of M2O leads to increased exposure to regorafenib in the body because it is not metabolized by CYP3A4 enzymes.</p>Fórmula:C21H15ClF4N4O4Pureza:Min. 95%Peso molecular:498.81 g/mol(aR)-a-Methyl-N-[3-[4-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine
CAS:<p>(aR)-a-Methyl-N-[3-[4-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine is a synthetic drug product that is used in research and development. It has been shown to have an analytical purity of 99.8%.</p>Fórmula:C22H22F3NPureza:Min. 95%Peso molecular:357.41 g/mol1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarboxaldehyde oxime
CAS:<p>1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarboxaldehyde oxime is an impurity in the drug product of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran. It is a metabolite that is formed during the metabolism of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran by cytochrome P450 enzymes. The CAS number for this compound is 227954–88–3. This chemical is not found in nature and can be synthesized in the laboratory.</p>Fórmula:C20H23FN2O2Pureza:Min. 95%Peso molecular:342.41 g/mola,a'-[[[2-(3,4-Dimethoxyphenyl)ethyl]imino]di-3,1-propanediyl]bis[3,4-dimethoxy-α-(1-methylethyl)-benzeneacetonitrile
CAS:<p>2,3,4-Trimethoxybenzaldehyde is an organic compound that is used as a chemical intermediate in the synthesis of pharmaceuticals. It is also used as a reagent in the chemical industry and as a flavoring agent. 2,3,4-Trimethoxybenzaldehyde has been shown to be metabolized by human liver microsomes to yield metabolites that are not well characterized. The impurities found in this drug product are 2-methoxy-5-methylphenol and 2,6-dimethoxyphenol.</p>Fórmula:C42H57N3O6Pureza:Min. 95%Peso molecular:699.92 g/molRacecadotril Impurity G
CAS:<p>Racecadotril Impurity G is an analytical impurity found in the drug Racecadotril. It has been observed as a minor component in HPLC standards and can be synthesized from natural or synthetic sources. Racecadotril Impurity G is not found in the pharmacopoeia and does not have a CAS number.</p>Fórmula:C19H21NO3SPureza:Min. 95%Peso molecular:343.44 g/molN-Hydroxy riluzole O-b-D-glucuronide
CAS:<p>N-Hydroxy riluzole O-b-D-glucuronide is an analytical standard and drug development metabolite. It is a metabolite of the anti-convulsant agent riluzole, which is used in the treatment of amyotrophic lateral sclerosis (ALS). Riluzole is converted to N-hydroxyl riluzole O-b-D-glucuronide in the liver by UDP glucuronosyltransferase. N-Hydroxyl riluzole O-b-D-glucuronide has been shown to block protein synthesis in rat kidney cells. It also blocks the conversion of amino acid tyrosine to dopa in dopaminergic neurons, and inhibits dopamine uptake into synaptosomes.</p>Fórmula:C14H13F3N2O8SPureza:Min. 95%Peso molecular:426.32 g/mol3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]sulfinyl]-N-(aminosulfonyl)propanimidamide
CAS:<p>3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]sulfinyl]-N-(aminosulfonyl)propanimidamide is a drug product that is custom synthesized. It has a purity of ≥ 98% and is used in analytical, metabolism studies, natural drug development, pharmacopoeia, and research and development. 3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]sulfinyl]-N-(aminosulfonyl)propanimidamide has an impurity standard of 5% and can be found under CAS No. 90237-03-9.</p>Fórmula:C8H15N7O3S3Pureza:Min. 95%Peso molecular:353.45 g/mol(R)-Pramipexole 2HCl
CAS:Produto Controlado<p>Dopamine (D2 and D3) receptor agonist; has anti-parkinsonian effects</p>Fórmula:C10H19Cl2N3SPureza:Min. 95%Peso molecular:283.067671,3-bis(1,1-Dimethylpropyl) benzene
CAS:<p>1,3-bis(1,1-Dimethylpropyl) benzene is a synthetic compound that is used in drug product formulation. It is also used as an analytical standard for the determination of 1,3-bis(1,1-dimethylethyl)benzene in drug products and as a natural impurity in API preparations. This compound is metabolized to 1,3-dibromobenzene and 1,2-dibromoethane during its metabolic process. The chemical properties of this compound are similar to those of other alkylbenzenes and it has been shown to have pharmacological effects such as analgesic and antiinflammatory activities.</p>Fórmula:C16H26Pureza:Min. 95%Peso molecular:218.38 g/molIsopropyl 2-(3-nitrobenzilidene)acetoacetate
CAS:<p>This isopropyl 2-(3-nitrobenzylidene)acetoacetate is a reaction solution that can be used to produce the antihypertensive drug, methyldopa. The reaction time required for this solution to react is about two hours. This product also contains chloride and calcium antagonist, which are added as catalysts. The rate of this reaction depends on the temperature and concentration of organic solvent. Crotonic acid, dihedral, and the yield of this reaction depend on the purity of reagents. Impurities in this product include isobutyl and methylbenzene, but these are not harmful to human health. This product also contains piperazine and thionyl chloride as impurities.</p>Fórmula:C14H15NO5Pureza:Min. 95%Peso molecular:277.27 g/molLinagliptin Impurity 18
CAS:Produto Controlado<p>Please enquire for more information about Linagliptin Impurity 18 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C22H23N7O2Pureza:Min. 95%Peso molecular:417.46 g/molEthyl 2-methoxy-5-sulfamoylbenzoate
CAS:<p>Ethyl 2-methoxy-5-sulfamoylbenzoate is a research and development impurity standard. It is a white to off-white crystalline solid that is soluble in water. The product has been synthesized for use as a drug product, synthetic, and in the synthesis of other compounds. It has also been used as a metabolite in metabolism studies and an analytical standard for HPLC.</p>Fórmula:C10H13NO5SPureza:Min. 95%Peso molecular:259.28 g/molApixaban Impurity 11
CAS:<p>Apixaban impurity 11 is an analytical standard used in research and development, drug development, and the production of API. It has a purity of 99.5% by HPLC and is a metabolite of apixaban. Apixaban impurity 11 has the CAS number 2204368-51-2 and is a Metabolite and Impurity standard for pharmacopoeia with a purity of 99.5% by HPLC. This product can be custom synthesized or natural with a purity of 99.5% by HPLC.</p>Fórmula:C29H31N5O5Pureza:Min. 95%Peso molecular:529.59 g/molSolifenacin impurity C
CAS:<p>Solifenacin impurity C is an impurity that is found in the drug product Solifenacin. It has been shown to be a natural metabolite and has been detected in human urine. Solifenacin impurity C is used as an analytical standard for HPLC analyses of solifenacin, and can also be used as a reference material for pharmacopoeia. The purity of this compound is 99%.</p>Fórmula:C31H28N2OPureza:Min. 95 Area-%Cor e Forma:White PowderPeso molecular:444.57 g/molAmiodarone EP Impurity G HCL
<p>Amiodarone is a drug product that is used in the treatment of various heart conditions. It contains impurity G and HCL. Impurity G is a metabolite that is found in the urine of patients who have taken Amiodarone and can be detected by HPLC. Impurity G has not been shown to be toxic to humans, but it may interfere with the metabolism of other drugs. The impurity standard for Amiodarone includes Impurity G, which is an analytical impurity, and Impurity HCL, which is an API impurity.</p>Fórmula:C26H31I2NO4·HClPureza:Min. 95%Peso molecular:711.8 g/molEthosuximide impurity A
CAS:<p>Ethosuximide impurity A is a fluorinated compound that inhibits the enzyme acetylcholinesterase. It has been shown to inhibit the catalytic mechanism of acetylcholinesterase, which leads to its inhibitory effect on the enzyme. The compound does not have any structural similarity to the other known inhibitors of this enzyme. Ethosuximide impurity A has been shown to be an antimutagen and anticarcinogen in vitro, with a postulated mechanism of action that involves inhibition of a water molecule from binding to the active site.</p>Fórmula:C7H12O4Pureza:Min. 95%Peso molecular:160.17 g/molEthyl (S)-1-phenyl-1,2,3,4-tetrahydro-2-isoquinolinecarboxylate
CAS:<p>Ethyl (S)-1-phenyl-1,2,3,4-tetrahydro-2-isoquinolinecarboxylate is an analytical standard used to identify impurities in drug products. It is a metabolite of the drug product and has been shown to be safe for human consumption. The compound is a synthetic chemical that is not found naturally in the environment. CAS No. 180468-42-2</p>Fórmula:C18H19NO2Pureza:Min. 95%Peso molecular:281.35 g/molBupropion (R)-Isomer
CAS:Produto Controlado<p>Bupropion is a racemic mixture of two enantiomers. The (R)-isomer is the more active form and is used for the treatment of major depressive disorder, seasonal affective disorder, and nicotine addiction. Bupropion has been shown to inhibit monoamine oxidase type A in humans and other mammals. This inhibition may be responsible for its antidepressant effects. The drug also has an effect on the liver, which can lead to serious side effects such as seizures or death if not monitored carefully. Bupropion has a high affinity for α1-acid glycoprotein, which plays a role in drug interactions with other drugs that are metabolized by this protein.</p>Fórmula:C13H18ClNOPureza:Min. 95%Peso molecular:239.74 g/mol1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone
CAS:<p>1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone is a drug product that is used as an HPLC standard. It is a natural metabolite of the drug product 1-[4-(4-Amino-6,7-dimethoxyquinazolinyl)-1piperazinyl]-5hydroxypentane. The synthesis of this compound has been reported in the literature.<br>The impurity content of this compound meets the pharmacopoeia requirements for an analytical reference standard for API impurities.</p>Fórmula:C19H27N5O4Pureza:Min. 95%Peso molecular:389.45 g/molSitagliptin hydroxy amide impurity
CAS:<p>Sitagliptin is an oral dipeptidyl peptidase-4 inhibitor that is used to treat type 2 diabetes. It binds to the active site of the enzyme and reversibly blocks the action of the enzyme, thereby inhibiting the breakdown of a number of important hormones such as glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide. Sitagliptin hydroxy amide impurity is an impurity in sitagliptin that inhibits oxidoreductases, enzymes that catalyze oxidation reactions. The enantiomeric purity of sitagliptin hydroxy amide impurity is unknown.</p>Fórmula:C16H14F6N4O2Pureza:Min. 95%Peso molecular:408.3 g/mol4',4'''-[(4'-Methyl-2'-propyl[2,6'-bi-1H-benzimidazole]-1,1'-diyl)bis(methylene)]bis[1,1'-biphenyl]-2-carboxylic acid
CAS:<p>4',4'''-[(4'-Methyl-2'-propyl[2,6'-bi-1H-benzimidazole]-1,1'-diyl)bis(methylene)]bis[1,1'-biphenyl]-2-carboxylic acid is an analytical reagent that is used in research and development as a drug product impurity standard. This compound has been shown to be metabolized by cytochrome P450 1A1 and 2C8 to form 4-hydroxybenzoic acid and 4,4''-[(4'-methyl-2' propyl-[2,6']bi-1H-benzimidazol-1,1' diyl)bis(methylene)]bis[3-(4-hydroxyphenyl)-propionic acid], respectively. 4',4''-[(4'-Methyl-2' propyl-[2,6']bi-1</p>Fórmula:C46H38N4O4Pureza:Min. 95%Peso molecular:710.82 g/molN,N'-Dimethyl-2-nitro-1,1-ethendiamine
CAS:<p>N,N'-Dimethyl-2-nitro-1,1-ethendiamine is a protonated form of N,N'-dimethyl-2-nitroetheneamine. It has been shown to be an equilibrating agent for the equilibrium between the protonated and unprotonated forms of N,N'-dimethyl-2-nitroetheneamine in alkaline solution. In this way it can be used to determine the pH of an unknown solution. The equilibrium constant is 10^14 at 25 degrees Celsius. This constant varies with temperature and concentration of N,N'-dimethyl-2-nitroetheneamine. The electronic spectra show that this molecule is an anion.</p>Fórmula:C4H9N3O2Pureza:Min. 95%Peso molecular:131.13 g/molrac-N-Desisopropyl-N-ethyl acebutolol
CAS:<p>rac-N-Desisopropyl-N-ethyl acebutolol is a synthetic drug product. It is an analytical standard for the impurity, acebutolol, and is metabolized by cytochrome P450 3A4 to form the major metabolite, N-desisopropyl acebutolol. rac-N-Desisopropyl-N-ethyl acebutolol is a research and development product that can be custom synthesized to meet specific needs. It has been shown to have antihypertensive properties in rats and monkeys. This product is not intended for human use.</p>Fórmula:C17H26N2O4Pureza:Min. 95%Peso molecular:322.4 g/mol
![3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-7,8-dihydro-2-methyl-4H-pyrido[1,2-a…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIF24786.webp&w=3840&q=75)
![3-[2-[4-(1,2-Benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]p…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIB21194.webp&w=3840&q=75)
![(3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIE22671.webp&w=3840&q=75)
![1-[(1-Methylethyl)amino]-3-phenoxy-2-propanol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIM63785.webp&w=3840&q=75)
![[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl](4-hydroxyphenyl)-methanone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIH44805.webp&w=3840&q=75)
![2-[[2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIO183175.webp&w=3840&q=75)
![1-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIM25690.webp&w=3840&q=75)
![3-[2-[4-(6-Fluoro-2-benzoxazolyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIF23377.webp&w=3840&q=75)
![N-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIO28664.webp&w=3840&q=75)
![3-[(1E)-2-[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]diazenyl] balsalazide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIC19769.webp&w=3840&q=75)
![2-[3-[4-(3-Chloro-4-ethylphenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIC171026.webp&w=3840&q=75)
![5-Chloro-N-[3-[[(5-chloro-2-thienyl)carbonyl]amino]-2-hydroxypropyl]-N-[4-(3-oxo-4-morpholinyl)phe…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIC183209.webp&w=3840&q=75)
-methanone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIA63847.webp&w=3840&q=75)
![6,7,8,9-Tetrahydro-3-[2-[4-(6-methoxy-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-4H-pyri…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIT81401.webp&w=3840&q=75)
![a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-propyl-benzeneacetonitrile](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FID145564.webp&w=3840&q=75)
![2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIP27062.webp&w=3840&q=75)
![2-[[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIC20741.webp&w=3840&q=75)
![[1,1'-Biphenyl]-2'-(2H-tetrazol-5-yl)-4-carboxylic acid, [1,1'-biphenyl]-(2'-(2H-tetrazol-5-yl)-4-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIB18639.webp&w=3840&q=75)
![(2R)-2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-isopropylpentanenitril…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FID28684.webp&w=3840&q=75)
![(aR)-a-Methyl-N-[3-[4-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIM101358.webp&w=3840&q=75)
![1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarboxaldehyde oxime](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FID182715.webp&w=3840&q=75)
![a,a'-[[[2-(3,4-Dimethoxyphenyl)ethyl]imino]di-3,1-propanediyl]bis[3,4-dimethoxy-α-(1-methylethyl)-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FID145565.webp&w=3840&q=75)
![3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]sulfinyl]-N-(aminosulfonyl)propanimidamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIA182983.webp&w=3840&q=75)
![1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIA63845.webp&w=3840&q=75)
![4',4'''-[(4'-Methyl-2'-propyl[2,6'-bi-1H-benzimidazole]-1,1'-diyl)bis(methylene)]bis[1,1'-biphenyl…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIM28023.webp&w=3840&q=75)
